Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TachoSil is an absorbable fibrin sealant patch used as a topical adjunct to hemostasis during surgery. It consists of human fibrinogen and human thrombin coated onto an equine collagen sponge. Upon contact with blood or other fluids, the active components are activated, leading to the formation of a fibrin clot that adheres the patch to tissue surfaces, promoting local hemostasis and tissue sealing. TachoSil is indicated for use in adult and pediatric patients (from 1 month of age) in cardiovascular, hepatic, and neurological surgeries when standard surgical techniques are ineffective or impractical. In neurosurgery, it is also used to seal dura mater and prevent cerebrospinal fluid leakage. The patch dissolves completely after application[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tachosil.